Table 1 The related prognostic influencing factors of UTUCs and the risk factors of bladder cancer recurrence in this study
Influential factors | Classification | No. of patients (%) |
|---|---|---|
Sex | Male | 236(53.7%) |
Female | 203(46.3%) | |
Age | <50 yr | 132(30.1%) |
≥50 yr | 307(69.9%) | |
Smoking | Yes | 204(46.5%) |
No | 235(53.5%) | |
TCHAA | Yes | 173(39.4%) |
No | 166(60.6%) | |
History of BC | Yes | 95(9.2%) |
No | 344(90.8%) | |
DM | Yes | 133(30.3%) |
No | 306(69.7%) | |
DM + metformin use | Yes | 53(39.8%) |
No | 80(60.2%) | |
Number of tumors | Single | 278(63.3%) |
Multiple | 161(36.7%) | |
Tumor location | Renal pelvis | 253(57.6%) |
Ureter | 140(42.4%) | |
Tumor stage | T1-T2 | 246(56.0%) |
T3-T4 | 193(44.0%) | |
Tumor size | <3 cm ≥3 cm | 255(58.1%) 184(41.9%) |
Tumor grade | G1-G2 | 352(80.2%) |
G3 | 87(19.8%) | |
LNM | Yes No | 86(19.6%) 353(80.4%) |
Preoperative Ureteroscopy | Yes | 139(31.7%) |
No | 300(68.3%) | |
Operation mode | Laparoscopic surgery | 312(71.1%) |
Open surgery | 127 (28.9%) | |
BC recurrence | Â | 89(20.3%) |
Renal pelvis carcinoma | 30(33.7%) | |
Ureteral carcinoma | 59(66.3%) | |
242 cases of PBPC | 28(11.6%) | |
197 cases of no PBPC | 61(31.0%) | |
DM | 63(70.9%) | |
DM with Metformin use | 15(16.9%) | |
DM without metformin use | 48(53.9%) |